These results, along with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two help the notion of targeting ACKR3 as a unique strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant disorders. In reaction to this situation, https://jimmyb367oii9.activablog.com/profile